Metraipolis › archive › dc_da0856c8f0ab

In Vivo Therapeutic Potential of Next-Generation Probiotic Akkermansia muciniphila and Butyrate Combination Therapy in Diabetes — Europe PMC PMID:41162165

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41162165
DOI
10.4014/jmb.2506.06025
License (as archived)
solo-consultazione
Archived
2026-11-09T00:25:26.102Z
SHA-256 of the archived text
8bfdb838cc38aa317deaa9b13ebf267b74e19b14202e115df30f201c44d8becd
Stable URL of this page
https://metraipolis.com/documento/dc_da0856c8f0ab

How to cite

In Vivo Therapeutic Potential of Next-Generation Probiotic Akkermansia muciniphila and Butyrate Combination Therapy in Diabetes — Europe PMC PMID:41162165 — Europe PMC (en), https://europepmc.org/article/MED/41162165 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da0856c8f0ab (Metraipolis archive dc_da0856c8f0ab, sha256 8bfdb838cc38aa317deaa9b13ebf267b74e19b14202e115df30f201c44d8becd)
BibTeX
@misc{dcda0856c8f0ab,
  title = {In Vivo Therapeutic Potential of Next-Generation Probiotic Akkermansia muciniphila and Butyrate Combination Therapy in Diabetes — Europe PMC PMID:41162165},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41162165},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da0856c8f0ab; sha256 8bfdb838cc38aa317deaa9b13ebf267b74e19b14202e115df30f201c44d8becd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41162165. Agents can read the archived copy with the MCP tool read_document.